Allogene discontinues investigational antibody following patient death

BMS and venture capital giant form new company

Novo Nordisk appoints Mike Doustdar as new CEO

Novo Nordisk cuts ties with Hims & Hers after Wegovy dispute

Lund University’s record-breaking recruitment – attracting researchers from around the world

FDA approves Gilead’s HIV injection: “Historic day”

Agreement in the EU on eight years of data exclusivity for new medicines

US Health Secretary Kennedy dismisses all vaccine experts – assembles new committee

Charged with illegal pharmaceutical sales – alleged earnings of 23 million

Positive EMA Decision for BioArctic's New Drug Candidate

The race between new alzheimer’s drugs Kisunla and Leqembi heats up

Venomaid's rapid test aims to find the right snake bite treatment

Virology professor on the threat from X: ”The next pandemic could be worse“

The scientist behind Novo Nordisk's obesity success: “I never stopped believing in GLP-1”

Icelandic pharmaceutical company Alvotech to list on Nasdaq Stockholm

AstraZeneca´s Trixeo approved in the UK using propellant with near-zero Global Warming Potential

Trump in new push to lower drug prices

Getinge and Neobiomics received Swecare's export awards

Astra Zeneca faces potential multimillion-dollar fines in China

Merck KGaA acquires American company in €3.0 billion deal

Eli Lilly requests re-examination of Alzheimer's drug recommendation

Mikael Kubista back with new venture after turbulent exit

New moves around Nykode's management – withdrawal of resignations

After the threat of tariffs – Novartis invests 230 billion in the USA

FDA plans to replace animal testing with AI – “Paradigm shift”

From pharmacist to life science podcaster – Magnus Lejelöv uses his voice as a tool

Korbinian Löbmann leads scientific meeting on drug formulation: High activity in the field

Tau-targeted Alzheimer's drug gets Fast Track designation in the USA

FDA’s Top Vaccine Official resigns – Issues sharp criticism of Kennedy

Success for Genmab's antibody-drug conjugate

Vaccine skeptic David Geier to lead study on link to autism

Several departures at the top at Nykode

An organ seldom in the spotlight – but utterly vital

Cancer researcher: “We can do better and reduce suffering”

Quretech granted a European patent for a new type of antibiotic

Aqilion's licensing journey: From Merck partnership to new opportunities

Positive trend for Swedish medtech exports – “We have new markets that are huge”